Nano Labs Announces First Half Of 2026 Financial Results
| US/Canada: | 1855 883 1031 |
| Hong Kong: | 800 930 639 |
| China: | 400 1209 216 |
| Replay PIN: | 10056588 |
About Nano Labs Ltd
Nano Labs Ltd is a leading Web 3.0 infrastructure provider and crypto treasury company. Nano Labs has actively positioned itself in the crypto assets space, adopting BNB as its primary reserve asset. It has reserved in mainstream cryptocurrencies BNB, and committed to the product iPollo ClawPC A1 Mini, designed to support the OpenClaw AI Agent system and a broad range of applications, including gaming and entertainment, professional content creation, and intelligent office scenarios. For more information, please visit the Company's website at: ir.nano.cn.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company's plan to appeal the Staff's determination, which can be identified by terminology such as“may,”“will,”“expect,”“anticipate,”“aim,”“estimate,”“intend,”“plan,”“believe,”“potential,”“continue,”“is/are likely to” or other similar expressions. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor and media inquiries, please contact:
Nano Labs Ltd
Email: ...
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: ...
| Consolidated Balance Sheets | ||||||||||||
| (Unaudited) | ||||||||||||
| As of December 31, | As of June 30, | |||||||||||
| 2025 | 2026 | |||||||||||
| RMB | RMB | US$ | ||||||||||
| ASSETS | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | 8,502,357 | 8,957,513 | 1,315,173 | |||||||||
| Restricted cash | 1,347,795 | - | - | |||||||||
| Accounts receivable, net | 281,446 | 338,567 | 49,710 | |||||||||
| Inventories, net | 13,693,374 | 4,318,470 | 634,053 | |||||||||
| Prepayments | 7,567,871 | 5,098,671 | 748,605 | |||||||||
| Short-term investments | 26,214,992 | 3,718,561 | 545,972 | |||||||||
| Receivable for cryptocurrencies collateral | 20,387,316 | - | - | |||||||||
| Cryptocurrencies, current | 343,812,102 | 108,987,050 | 16,001,857 | |||||||||
| Cryptocurrencies, restricted | - | 24,593,343 | 3,610,880 | |||||||||
| Derivative assets | - | 41,704,830 | 6,123,248 | |||||||||
| Other current assets | 9,057,772 | 9,188,636 | 1,349,107 | |||||||||
| Total current assets | 430,865,025 | 206,905,641 | 30,378,605 | |||||||||
| Non-current assets: | ||||||||||||
| Long-term investment | 2,000,000 | 12,000,000 | 1,761,882 | |||||||||
| Property, plant and equipment, net | 182,630,671 | 177,163,859 | 26,011,813 | |||||||||
| Intangible asset, net | 45,759,600 | 45,266,678 | 6,646,211 | |||||||||
| Value-added tax recoverables, non-current | 30,414,877 | 29,628,154 | 4,350,109 | |||||||||
| Cryptocurrencies, non-current | 424,743,318 | 259,780,228 | 38,141,836 | |||||||||
| Operating lease right-of-use assets | 3,090,851 | 5,955,147 | 874,355 | |||||||||
| Total non-current assets | 688,639,317 | 529,794,066 | 77,786,206 | |||||||||
| TOTAL ASSETS | 1,119,504,342 | 736,699,707 | 108,164,811 | |||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||
| Current liabilities: | ||||||||||||
| Short-term debts | 43,000,000 | 23,000,000 | 3,376,940 | |||||||||
| Current portion of long-term debts | 6,890,000 | 7,660,000 | 1,124,668 | |||||||||
| Borrowings denominated in cryptocurrencies | 11,948,960 | 17,708,340 | 2,600,000 | |||||||||
| Accounts payable | 19,424,629 | 12,705,052 | 1,865,400 | |||||||||
| Advance from customers | 69,314,154 | 63,000,107 | 9,249,895 | |||||||||
| Operating lease liabilities, current | 1,125,674 | 2,372,382 | 348,321 | |||||||||
| Other current liabilities | 54,303,126 | 46,269,332 | 6,793,424 | |||||||||
| Total current liabilities | 206,006,543 | 172,715,213 | 25,358,648 | |||||||||
| Non-current liabilities: | ||||||||||||
| Long-term debts | 170,902,834 | 174,969,625 | 25,689,648 | |||||||||
| Operating lease liabilities, non-current | 1,696,750 | 3,416,589 | 501,635 | |||||||||
| Total non-current liabilities | 172,599,584 | 178,386,214 | 26,191,283 | |||||||||
| Total liabilities | 378,606,127 | 351,101,427 | 51,549,931 | |||||||||
| Shareholders' equity: | ||||||||||||
| Class A ordinary shares (US$0.002 par value; 1,097,141,091 shares authorized as of December 31, 2025 and June 30, 2026; 20,712,924 shares issued as of December 31, 2025 and June 30, 2026; 20,185,908 and 19,147,732 shares outstanding as of December 31, 2025 and June 30, 2026, respectively) | 283,565 | 283,623 | 41,643 | |||||||||
| Class B ordinary shares (US$0.002 par value; 2,858,909 shares authorized; 2,858,909 shares issued and outstanding as of December 31, 2025 and June 30, 2026) | 36,894 | 36,894 | 5,417 | |||||||||
| Treasury shares | (1,666,859 | ) | (19,706,651 | ) | (2,893,399 | ) | ||||||
| Additional paid-in capital | 1,180,196,429 | 1,180,208,542 | 173,282,318 | |||||||||
| Accumulated deficit | (429,752,701 | ) | (739,256,469 | ) | (108,540,203 | ) | ||||||
| Statutory reserves | 6,647,109 | 6,647,109 | 975,952 | |||||||||
| Accumulated other comprehensive loss | (7,450,495 | ) | (28,041,650 | ) | (4,117,172 | ) | ||||||
| Total Nano Labs Ltd shareholders' equity | 748,293,942 | 400,171,398 | 58,754,556 | |||||||||
| Noncontrolling interests | (7,395,727 | ) | (14,573,118 | ) | (2,139,676 | ) | ||||||
| Total shareholders' equity | 740,898,215 | 385,598,280 | 56,614,880 | |||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 1,119,504,342 | 736,699,707 | 108,164,811 |
| Consolidated Statements of Operations and Comprehensive Income (Loss) | ||||||||||||
| (Unaudited) | ||||||||||||
| For the six months ended June 30, | ||||||||||||
| 2025 | 2026 | |||||||||||
| RMB | RMB | US$ | ||||||||||
| Net revenues | 8,283,373 | 2,778,378 | 407,931 | |||||||||
| Cost of revenues | (18,991,737 | ) | (8,625,388 | ) | (1,266,409 | ) | ||||||
| Gross loss | (10,708,364 | ) | (5,847,010 | ) | (858,478 | ) | ||||||
| Operating income (expenses): | ||||||||||||
| Selling and marketing expenses | (2,617,584 | ) | (3,061,642 | ) | (449,521 | ) | ||||||
| General and administrative expenses | (21,544,148 | ) | (27,898,411 | ) | (4,096,142 | ) | ||||||
| Research and development expenses | (3,163,558 | ) | (4,422,485 | ) | (649,325 | ) | ||||||
| Change in fair value of cryptocurrencies | 48,610,295 | (250,465,136 | ) | (36,774,161 | ) | |||||||
| Total operating income (expenses) | 21,285,005 | (285,847,674 | ) | (41,969,149 | ) | |||||||
| Profit (Loss) from operations | 10,576,641 | (291,694,684 | ) | (42,827,627 | ) | |||||||
| Other income (expenses): | ||||||||||||
| Finance expenses | (274,189 | ) | (740,278 | ) | (108,690 | ) | ||||||
| Interest expenses | (5,287,620 | ) | (5,254,957 | ) | (771,551 | ) | ||||||
| Interest income | 12,322 | 2,951 | 433 | |||||||||
| Change in fair value of derivative assets | - | (2,767,854 | ) | (406,386 | ) | |||||||
| Change in fair value of borrowings denominated in cryptocurrencies | (18,529,435 | ) | - | - | ||||||||
| Other income | 1,724,344 | 2,063,759 | 303,008 | |||||||||
| Other expenses | - | (18,309,645 | ) | (2,688,286 | ) | |||||||
| Total other expenses | (22,354,578 | ) | (25,006,024 | ) | (3,671,472 | ) | ||||||
| Loss before income tax provision | (11,777,937 | ) | (316,700,708 | ) | (46,499,099 | ) | ||||||
| Income tax provision | - | - | - | |||||||||
| Net loss | (11,777,937 | ) | (316,700,708 | ) | (46,499,099 | ) | ||||||
| Less: net loss attributable to noncontrolling interests | (4,723,396 | ) | (7,196,940 | ) | (1,056,680 | ) | ||||||
| Net loss attributable to Nano Labs Ltd | (7,054,541 | ) | (309,503,768 | ) | (45,442,419 | ) | ||||||
| Comprehensive loss: | ||||||||||||
| Net loss | (11,777,937 | ) | (316,700,708 | ) | (46,499,099 | ) | ||||||
| Other comprehensive loss: | ||||||||||||
| Foreign currency translation adjustment | (1,840,888 | ) | (20,571,606 | ) | (3,020,395 | ) | ||||||
| Total comprehensive loss | (13,618,825 | ) | (337,272,314 | ) | (49,519,494 | ) | ||||||
| Comprehensive loss attributable to noncontrolling interests | (4,722,335 | ) | (7,177,391 | ) | (1,053,809 | ) | ||||||
| Comprehensive loss attributable to Nano Labs Ltd | (8,896,490 | ) | (330,094,923 | ) | (48,465,685 | ) | ||||||
| Net loss per ordinary share attributable to Nano Labs Ltd | ||||||||||||
| Basic | (0.43 | ) | (13.65 | ) | (2.00 | ) | ||||||
| Diluted | (0.43 | ) | (13.65 | ) | (2.00 | ) | ||||||
| Weighted average number of shares used in per share calculation: | ||||||||||||
| Basic | 16,548,783 | 22,674,071 | 22,674,071 | |||||||||
| Diluted | 16,548,783 | 22,674,071 | 22,674,071 |
| Non-GAAP Reconciliation | ||||||||||||
| (Unaudited) | ||||||||||||
| For the Six Months Ended June 30, | ||||||||||||
| 2025 | 2026 | |||||||||||
| RMB | RMB | US$ | ||||||||||
| Net loss | (11,777,937 | ) | (316,700,708 | ) | (46,499,099 | ) | ||||||
| Add: | ||||||||||||
| Share-based compensation expenses | 62,337 | 12,113 | 1,778 | |||||||||
| Non-GAAP adjusted net loss | (11,715,600 | ) | (316,688,595 | ) | (46,497,321 | ) |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment